This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Mar;51(3):1072-6.

doi: 10.1002/hep.23579.

Preventing hepatitis C virus recurrence in liver transplant recipients: a role for adoptive immunotherapy?

Jean-Michel Pawlotsky¹, Stéphane Chevaliez

Affiliations

Affiliation

¹ Institut National de la Santé et de la Recherche Médicale Unité 955 and National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor Hospital, University of Paris 12, Créteil, France.

PMID: 20198701
DOI: 10.1002/hep.23579

Comment

Preventing hepatitis C virus recurrence in liver transplant recipients: a role for adoptive immunotherapy?

Jean-Michel Pawlotsky et al. Hepatology. 2010 Mar.

. 2010 Mar;51(3):1072-6.

doi: 10.1002/hep.23579.

Authors

Jean-Michel Pawlotsky¹, Stéphane Chevaliez

Affiliation

¹ Institut National de la Santé et de la Recherche Médicale Unité 955 and National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor Hospital, University of Paris 12, Créteil, France.

PMID: 20198701
DOI: 10.1002/hep.23579

No abstract available

PubMed Disclaimer

Comment on

Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.
Ohira M, Ishiyama K, Tanaka Y, Doskali M, Igarashi Y, Tashiro H, Hiraga N, Imamura M, Sakamoto N, Asahara T, Chayama K, Ohdan H. Ohira M, et al. J Clin Invest. 2009 Nov;119(11):3226-35. doi: 10.1172/JCI38374. Epub 2009 Oct 1. J Clin Invest. 2009. PMID: 19805910 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley